Trademark: RESET MIND SCIENCES 2199549
Word
RESET MIND SCIENCES
ID
2199549
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
03 August 2021
Registration Date
03 August 2021
Renewal Date
03 August 2031
Owner(s)
Service
Griffith Hack
Goods and Services:
Class 5:
Medical psychedelics and derivatives thereof; Serotonergic psychedelics including but not limited to LSD (Lysergic acid diethylamide), Psilocybin, Psilocin, Mescaline, DMT (Diemethyltryptamine), Peyote (Lophophora williamsii) and Ibogaine; Empathogens/Entactogens including but not limited to MDMA (3,4Methylenedioxymethamphetamine); psychedelic products, including oils, salves, concentrated pastes, therapeutic creams and tinctures; pharmaceutical preparations and substances for the prevention, management and treatment of disorders of the brain and the human body, depressive illness, anxiety and mood disorders, personality disorders, post traumatic stress disorder, substance addiction
Medical psychedelics and derivatives thereof; Serotonergic psychedelics including but not limited to LSD (Lysergic acid diethylamide), Psilocybin, Psilocin, Mescaline, DMT (Diemethyltryptamine), Peyote (Lophophora williamsii) and Ibogaine; Empathogens/Entactogens including but not limited to MDMA (3,4Methylenedioxymethamphetamine); psychedelic products, including oils, salves, concentrated pastes, therapeutic creams and tinctures; pharmaceutical preparations and substances for the prevention, management and treatment of disorders of the brain and the human body, depressive illness, anxiety and mood disorders, personality disorders, post traumatic stress disorder, substance addiction
Class 42:
Pharmaceutical research services; Research relating to pharmaceuticals, including psychedelics; Services for assessing the efficiency of pharmaceuticals, including psychedelics; Services for assessing the safety of pharmaceuticals, including psychedelics; Conducting clinical trials; Managing clinical trials
Pharmaceutical research services; Research relating to pharmaceuticals, including psychedelics; Services for assessing the efficiency of pharmaceuticals, including psychedelics; Services for assessing the safety of pharmaceuticals, including psychedelics; Conducting clinical trials; Managing clinical trials